GLP1R and familial dilated cardiomyopathy: Currently, the conventional treatment of DCM drugs include metformin, thiazolidinediones (TZDs), sulfonylureas, Glucagon-like peptide-1 receptor (GLP-1R) agonists, dipeptidyl peptidase-4 (DPP-4) inhibitors, SLGT-2 inhibitors and angiotensin-converting enzyme inhibitors (ACEI).